Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.67 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9826758 | 0.87 | MAOB (0.52) | MAOBCA1CA2ARG2TSHR | |
| SCHEMBL7041057 | 0.84 | MAOB (0.50) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL13733896 | 0.84 | FNTA (0.54) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL9770101 | 0.84 | LMNA (0.50) | MAOBTSHRIDO1ALDH1A1TP53 | |
| SCHEMBL365818 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 | |
| SCHEMBL7301824 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 | |
| SCHEMBL3755335 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 | |
| SCHEMBL185486 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 | |
| SCHEMBL118087 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 | |
| SCHEMBL1005335 | 0.83 | MAOB (0.55) | MAOBCALM1CA1CA2ARG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112831335-B | Method for preparing mesophase pitch and mesophase carbon microspheres from heavy oil | 中国石油大学(华东) | 2022-05-10 | — | — | CN | claimed |
| CN-112831334-A | Preparation method of mesophase pitch and mesophase carbon microspheres | 中国石油大学(华东) | 2021-05-25 | — | — | CN | claimed |
| CN-112831335-A | Method for preparing mesophase pitch and mesophase carbon microspheres from heavy oil | 中国石油大学(华东) | 2021-05-25 | — | — | CN | claimed |
| US-20170313661-A1 | KINASE MODULATORS FOR THE TREATMENT OF CANCER | SYNOVO GMBH (DE) | 2017-11-02 | — | — | US | claimed |
| US-9416123-B2 | Kinase modulators for the treatment of cancer | SYNOVO GMBH (DE) | 2016-08-16 | — | — | US | claimed |
| US-20140336225-A1 | KINASE MODULATORS FOR THE TREATMENT OF CANCER | SYNOVO GMBH (DE) | 2014-11-13 | — | — | US | claimed |
| CN-102066442-B | Polymacromonomer and process for production thereof | EXXONMOBIL CHEM PATENTS INC | 2013-10-02 | — | — | CN | claimed |
| EP-2078002-B1 | 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS | MERCK SHARP & DOHME (US) | 2013-08-28 | — | — | EP | claimed |
| WO-2013078240-A1 | N-BIPHENYLMETHYLBENZIMIDAZOLE MODULATORS OF PPARG | RIPKA AMY S (US) | 2013-05-30 | — | — | WO | claimed |
| WO-2013046041-A1 | PYRIDINYLPYRAZOLES FOR USE AS KINASE MODULATORS FOR THE TREATMENT OF CANCER | SYNOVO GMBH (DE) | 2013-04-04 | — | — | WO | claimed |
| US-5246969-A | Oligopeptides as renin inhibitors | G. D. SEARLE & CO. (US) | 1993-09-21 | — | — | US | claimed |
| US-5118688-A | TETRAHYDROPYRIDOQUINOLONE DERIVATIVES USEFUL AS ANXIOLYTIC AGENTS | ICI AMERICAS INC. (US) | 1992-06-02 | — | — | US | claimed |
| US-4976889-A | 4-formylaminopiperidine derivatives, their use as stabilizers and organic material stabilized with the said derivatives | BASF AKTIENGESELLSCHAFT (DE) | 1990-12-11 | — | — | US | claimed |
| EP-0363284-A2 | Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes | MERRELL PHARMACEUTICALS INC. (US) | 1990-04-11 | — | — | EP | claimed |
| EP-0183191-B1 | THIENYLTHIAZOLE COMPOUNDS | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1989-05-10 | — | — | EP | claimed |
| EP-0230151-A2 | Cholecystokinin antagonists | BIOMEASURE, INC. (US) | 1987-07-29 | — | — | EP | claimed |
| US-4521412-A | Pesticidal iodopropargylammonium salts | BAYER AKTIENGESELLSCHAFT (DE) | 1985-06-04 | — | — | US | claimed |
| US-4220649-A | VASODILATORS AND HYPOTENSIVE AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1980-09-02 | — | — | US | claimed |
| US-4100344-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1978-07-11 | — | — | US | claimed |
| US-4028354-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1977-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170313661-A1 | KINASE MODULATORS FOR THE TREATMENT OF CANCER | MAP3K10, MAP3K12, MAP3K20 | MAOB 4305/4885CALM1 577/4885CA1 3348/4885 |
| US-20140336225-A1 | KINASE MODULATORS FOR THE TREATMENT OF CANCER | DCK, MAP3K2, MAP3K19 | MAOB 4144/4885CALM1 621/4885CA1 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.